bromocriptine has been researched along with arginine vasopressin in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (77.78) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Waters, AK | 1 |
de Vries, HW; Hellebrekers, LJ; Lagerweij, E; van Wimersma Greidanus, TB | 1 |
Abraham, RR; Altaher, AR; Campbell, EA; Gillham, B; Jenkins, J; Jones, MT; Prysor-Jones, A; Thody, AJ; Wynn, V | 1 |
Chiodera, P; Coiro, V | 1 |
Berl, T; Bichet, D; Kern, PA; Robbins, RJ; Verbalis, JG | 1 |
Cheung, CY | 1 |
Clifton-Bligh, P; Morris, BJ; Posen, S; Robinson, BG | 1 |
Mol, JA; Willemse, T | 1 |
1 review(s) available for bromocriptine and arginine vasopressin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for bromocriptine and arginine vasopressin
Article | Year |
---|---|
Augmentation of vasopressin antidiuresis by prolactin with a note on the contamination of International Standard prolactin.
Topics: Animals; Arginine Vasopressin; Bromocriptine; Diuresis; Drug Contamination; Drug Interactions; Male; Prolactin; Rats; Thyrotropin; Thyrotropin-Releasing Hormone; Vasopressins | 1977 |
Volume-regulated arginine vasopressin release in conscious dogs. Evidence for dopaminergic or opioid modulation?
Topics: Animals; Arginine Vasopressin; Blood Pressure; Blood Volume; Bromocriptine; Dogs; Female; Heart Rate; Humans; Male; Naloxone; Receptors, Dopamine; Receptors, Opioid | 1988 |
The effect of ovine corticotrophin releasing factor (oCRF), bromocriptine and TRH on the secretion of ACTH and alpha-MSH in Nelson's syndrome and Cushing's disease.
Topics: Adrenocorticotropic Hormone; Adult; Animals; Arginine Vasopressin; Bromocriptine; Corticotropin-Releasing Hormone; Cushing Syndrome; Humans; Melanocyte-Stimulating Hormones; Middle Aged; Nelson Syndrome; Pituitary Neoplasms; Sheep; Thyrotropin-Releasing Hormone | 1986 |
Lack of effect of bromocriptine and domperidone on arginine-vasopressin response to insulin-induced hypoglycemia in normal men.
Topics: Adult; Arginine Vasopressin; Blood Glucose; Brain; Bromocriptine; Domperidone; Dopamine; Humans; Insulin; Male; Neural Pathways; Oxytocin; Synaptic Transmission | 1987 |
Syndrome of inappropriate antidiuresis in the absence of arginine vasopressin.
Topics: Adult; Arginine Vasopressin; Bromocriptine; Craniopharyngioma; Growth Hormone; Humans; Hydrocortisone; Inappropriate ADH Syndrome; Luteinizing Hormone; Male; Pituitary Neoplasms; Prolactin; Thyroxine | 1986 |
Prolactin suppresses luteinizing hormone secretion and pituitary responsiveness to luteinizing hormone-releasing hormone by a direct action at the anterior pituitary.
Topics: Animals; Arginine Vasopressin; Bromocriptine; Female; Gonadotropin-Releasing Hormone; In Vitro Techniques; Kinetics; Luteinizing Hormone; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains | 1983 |
The effect of bromocriptine on circulating vasopressin.
Topics: Adult; Arginine Vasopressin; Bromocriptine; Female; Humans; Male; Osmolar Concentration; Prolactin; Radioimmunoassay; Time Factors | 1982 |
Comparison of in vivo and in vitro corticotropin-releasing hormone-stimulated release of proopiomelanocortin-derived peptides in cats.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Bromocriptine; Cats; Cells, Cultured; Corticotropin-Releasing Hormone; Dexamethasone; Female; Haloperidol; Hydrocortisone; Injections, Intravenous; Male; Melanocyte-Stimulating Hormones; Pituitary Gland; Pro-Opiomelanocortin; Radioimmunoassay; Sheep | 1994 |